| | | | | Merck & Co Inc said on Tuesday its blockbuster cancer drug Keytruda won approval from the U.S. Food and Drug Administration to treat a type of head and neck cancer. | | |
| | | The only abortion clinic in Missouri can stay open after a St. Louis judge issued a preliminary injunction on Monday saying the state must make an "official" decision on the facility's license before it can be reviewed, a court document showed. | | |
| | | The U.S. Food and Drug Administration on Monday granted earlier-than-expected approval to Roche Holding AG's antibody-drug conjugate Polivy for treatment of patients with advanced lymphoma. | | |
| | | (Reuters Health) - While many people can pick up on signs of postpartum depression in new mothers, the same signs are often mistaken for something else or missed entirely in fathers, a British study suggests. | | |
| | | (Reuters Health) - Legalizing medical marijuana no longer appears to be linked with a drop in fatal opioid overdoses, according to a new U.S. study that calls into question the potential for cannabis to help fix the opioid crisis. | | |
| | | Insulin-dependent patients with type 2 diabetes saw a significant drop in their blood sugar levels after wearing Abbott Laboratories Inc's continuous glucose monitoring system for three months compared with when they were not using the device, researchers said on Saturday. | | |
| | | (Reuters Health) - Compared to smaller facilities, hospitals that provide complex care for critical illness or serious injury may find it harder to make patients happy, a U.S. study suggests. | | |
| | | (Reuters Health) - For middle-aged and older women, sleeping with the television or lights on has been linked with higher odds of becoming obese, in a recent U.S. study. | | |
| | | The United States' worst measles outbreak in a quarter-century spread to Idaho and Virginia last week as public health authorities on Monday reported 41 new cases of the highly contagious and sometimes deadly disease. | | |
| | | China said on Monday it will tighten regulations on human genetic material, putting checks on the passing of it abroad and insisting that any foreign companies or institutes wanting to use it in their work do so with a Chinese partner. | | |
| | | (Reuters Health) - In people at high risk for type 1 diabetes, 14 days of therapy with the experimental drug teplizumab delayed development of the disease by a year or more, according to results from a mid-stage study presented Sunday. | | |
|
| |
